• LAST PRICE
    7.0500
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.1420%)
  • Bid / Lots
    6.6000/ 10
  • Ask / Lots
    7.6000/ 5
  • Open / Previous Close
    7.0400 / 7.0400
  • Day Range
    Low 6.8000
    High 7.1500
  • 52 Week Range
    Low 2.4400
    High 8.8400
  • Volume
    99,857
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 7.04
TimeVolumeGLUE
09:32 ET11777.08
09:34 ET1006.99
09:41 ET1006.96
09:45 ET6006.91
09:48 ET1006.91
09:52 ET6006.95
09:54 ET4326.835
09:56 ET13007.01
09:57 ET5507.0367
09:59 ET14007.0325
10:03 ET1007.09
10:10 ET1826.9
10:12 ET1507.06
10:14 ET3006.925
10:15 ET1006.84
10:17 ET3006.845
10:19 ET5006.95
10:21 ET1006.85
10:24 ET2006.85
10:26 ET1006.84
10:28 ET1006.84
10:30 ET2006.9
10:32 ET1006.845
10:33 ET3006.84
10:37 ET1006.835
10:39 ET1006.835
10:42 ET11006.835
10:46 ET12046.925
10:50 ET1006.98
10:53 ET1006.98
11:02 ET2006.98
11:06 ET1006.94
11:08 ET3506.955
11:11 ET5146.96
11:22 ET10056.9864
11:27 ET2206.94
11:29 ET1007.01
11:31 ET15006.98
11:33 ET1007
11:36 ET6506.99
11:40 ET1006.95
11:49 ET2006.97
11:54 ET10026.94
11:58 ET17006.95
12:02 ET8066.935
12:12 ET2006.89
12:16 ET2006.91
12:21 ET1006.91
12:23 ET15006.96
12:30 ET3007
12:38 ET1007.01
12:39 ET2006.974
12:43 ET1006.96
12:45 ET1006.96
12:48 ET1006.97
12:50 ET18806.93
12:52 ET1006.97
12:56 ET2006.88
12:59 ET3006.91
01:06 ET7506.91
01:12 ET4006.825
01:15 ET2006.825
01:17 ET2006.85
01:21 ET3006.89
01:28 ET2006.835
01:30 ET3006.85
01:32 ET8006.81
01:33 ET1006.81
01:35 ET1006.81
01:37 ET7006.87
01:39 ET5156.825
01:46 ET1006.845
01:48 ET2006.84
01:50 ET2006.81
01:51 ET1006.87
01:53 ET2006.82
01:55 ET82716.9
02:00 ET1006.86
02:02 ET1006.885
02:08 ET1006.85
02:09 ET1006.85
02:11 ET1006.85
02:13 ET1006.85
02:18 ET1006.85
02:20 ET1006.88
02:26 ET2006.88
02:29 ET1006.91
02:33 ET16006.94
02:42 ET1006.98
02:45 ET1006.95
02:49 ET1006.97
02:51 ET2006.995
02:54 ET3377
02:56 ET1007.025
03:09 ET1007.11
03:12 ET2007.15
03:18 ET3007.13
03:20 ET10527.11
03:21 ET3007.07
03:25 ET1007.04
03:27 ET1017.045
03:30 ET8507.07
03:32 ET1007.08
03:38 ET1007.085
03:39 ET2007.09
03:41 ET9007.0857
03:43 ET11057.07
03:45 ET1007.06
03:48 ET1007.04
03:50 ET8007
03:52 ET10507.03
03:54 ET3007.05
03:56 ET14257.02
03:57 ET3007.02
03:59 ET12037.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLUE
Monte Rosa Therapeutics Inc
353.6M
-2.7x
---
United StatesFBLG
Fibrobiologics Inc
352.8M
-11.8x
---
United StatesGUTS
Fractyl Health Inc
352.3M
-4.1x
---
United StatesHUMA
Humacyte Inc
363.4M
-2.9x
---
United StatesAVIR
Atea Pharmaceuticals Inc
340.0M
-2.5x
---
United StatesNAUT
Nautilus Biotechnology Inc
367.8M
-5.8x
---
As of 2024-03-29

Company Information

Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and more. MGDs are small molecule drugs that employ the body’s natural protein destruction mechanisms to selectively degrade therapeutically relevant proteins. It has developed a degradation platform, called Quantitative and Engineered Elimination of Neosubstrates (QuEEN) to enable its target centric MGD discovery and development approach and its rational design of MGD product candidates. Its product candidate, MRT-2359, is an orally bioavailable MGD targeting the translation termination factor protein GSPT1. MRT-2359 is in clinical development for potential use in MYC-driven tumors, including metastatic non-small cell lung cancer, small cell lung cancer and neuroendocrine tumors. Its other product candidates include MRT-6160 and MRT-8102.

Contact Information

Headquarters
321 Harrison Avenue, Suite 900BOSTON, MA, United States 02118
Phone
617-949-2643
Fax
302-655-5049

Executives

Non-Executive Chairman of the Board
Alexander Mayweg
President, Chief Executive Officer, Director
Markus Warmuth
Chief Technology Officer
Sharon Townson
Chief Scientific Officer
Owen Wallace
General Counsel
Philip Nickson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$353.6M
Revenue (TTM)
$0.00
Shares Outstanding
50.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.64
Book Value
$3.57
P/E Ratio
-2.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.